Global Oral Polio Vaccines (OPV) Market Growth 2022-2028
- LP 4767727
- 99 Pages
- January 2022
- Pharmaceuticals
The United States Oral Polio Vaccines (OPV) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oral Polio Vaccines (OPV) market, reaching US$ million by the year 2028. As for the Europe Oral Polio Vaccines (OPV) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oral Polio Vaccines (OPV) players cover Sanofi, GSK, Bibcol, and Serum Institute, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Polio Vaccines (OPV) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Trivalent OPV
Bivalent OPV
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Public
Private
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Polio Vaccines (OPV) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oral Polio Vaccines (OPV) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oral Polio Vaccines (OPV) by Country/Region, 2017, 2022 & 2028
2.2 Oral Polio Vaccines (OPV) Segment by Type
2.2.1 Trivalent OPV
2.2.2 Bivalent OPV
2.3 Oral Polio Vaccines (OPV) Sales by Type
2.3.1 Global Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2022)
2.3.2 Global Oral Polio Vaccines (OPV) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oral Polio Vaccines (OPV) Sale Price by Type (2017-2022)
2.4 Oral Polio Vaccines (OPV) Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Oral Polio Vaccines (OPV) Sales by Application
2.5.1 Global Oral Polio Vaccines (OPV) Sale Market Share by Application (2017-2022)
2.5.2 Global Oral Polio Vaccines (OPV) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oral Polio Vaccines (OPV) Sale Price by Application (2017-2022)
3 Global Oral Polio Vaccines (OPV) by Company
3.1 Global Oral Polio Vaccines (OPV) Breakdown Data by Company
3.1.1 Global Oral Polio Vaccines (OPV) Annual Sales by Company (2020-2022)
3.1.2 Global Oral Polio Vaccines (OPV) Sales Market Share by Company (2020-2022)
3.2 Global Oral Polio Vaccines (OPV) Annual Revenue by Company (2020-2022)
3.2.1 Global Oral Polio Vaccines (OPV) Revenue by Company (2020-2022)
3.2.2 Global Oral Polio Vaccines (OPV) Revenue Market Share by Company (2020-2022)
3.3 Global Oral Polio Vaccines (OPV) Sale Price by Company
3.4 Key Manufacturers Oral Polio Vaccines (OPV) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Polio Vaccines (OPV) Product Location Distribution
3.4.2 Players Oral Polio Vaccines (OPV) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral Polio Vaccines (OPV) by Geographic Region
4.1 World Historic Oral Polio Vaccines (OPV) Market Size by Geographic Region (2017-2022)
4.1.1 Global Oral Polio Vaccines (OPV) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oral Polio Vaccines (OPV) Annual Revenue by Geographic Region
4.2 World Historic Oral Polio Vaccines (OPV) Market Size by Country/Region (2017-2022)
4.2.1 Global Oral Polio Vaccines (OPV) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oral Polio Vaccines (OPV) Annual Revenue by Country/Region
4.3 Americas Oral Polio Vaccines (OPV) Sales Growth
4.4 APAC Oral Polio Vaccines (OPV) Sales Growth
4.5 Europe Oral Polio Vaccines (OPV) Sales Growth
4.6 Middle East & Africa Oral Polio Vaccines (OPV) Sales Growth
5 Americas
5.1 Americas Oral Polio Vaccines (OPV) Sales by Country
5.1.1 Americas Oral Polio Vaccines (OPV) Sales by Country (2017-2022)
5.1.2 Americas Oral Polio Vaccines (OPV) Revenue by Country (2017-2022)
5.2 Americas Oral Polio Vaccines (OPV) Sales by Type
5.3 Americas Oral Polio Vaccines (OPV) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Polio Vaccines (OPV) Sales by Region
6.1.1 APAC Oral Polio Vaccines (OPV) Sales by Region (2017-2022)
6.1.2 APAC Oral Polio Vaccines (OPV) Revenue by Region (2017-2022)
6.2 APAC Oral Polio Vaccines (OPV) Sales by Type
6.3 APAC Oral Polio Vaccines (OPV) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Polio Vaccines (OPV) by Country
7.1.1 Europe Oral Polio Vaccines (OPV) Sales by Country (2017-2022)
7.1.2 Europe Oral Polio Vaccines (OPV) Revenue by Country (2017-2022)
7.2 Europe Oral Polio Vaccines (OPV) Sales by Type
7.3 Europe Oral Polio Vaccines (OPV) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Polio Vaccines (OPV) by Country
8.1.1 Middle East & Africa Oral Polio Vaccines (OPV) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oral Polio Vaccines (OPV) Revenue by Country (2017-2022)
8.2 Middle East & Africa Oral Polio Vaccines (OPV) Sales by Type
8.3 Middle East & Africa Oral Polio Vaccines (OPV) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Polio Vaccines (OPV)
10.3 Manufacturing Process Analysis of Oral Polio Vaccines (OPV)
10.4 Industry Chain Structure of Oral Polio Vaccines (OPV)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Polio Vaccines (OPV) Distributors
11.3 Oral Polio Vaccines (OPV) Customer
12 World Forecast Review for Oral Polio Vaccines (OPV) by Geographic Region
12.1 Global Oral Polio Vaccines (OPV) Market Size Forecast by Region
12.1.1 Global Oral Polio Vaccines (OPV) Forecast by Region (2023-2028)
12.1.2 Global Oral Polio Vaccines (OPV) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Polio Vaccines (OPV) Forecast by Type
12.7 Global Oral Polio Vaccines (OPV) Forecast by Application
13 Key Players Analysis
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Oral Polio Vaccines (OPV) Product Offered
13.1.3 Sanofi Oral Polio Vaccines (OPV) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Oral Polio Vaccines (OPV) Product Offered
13.2.3 GSK Oral Polio Vaccines (OPV) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Bibcol
13.3.1 Bibcol Company Information
13.3.2 Bibcol Oral Polio Vaccines (OPV) Product Offered
13.3.3 Bibcol Oral Polio Vaccines (OPV) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bibcol Main Business Overview
13.3.5 Bibcol Latest Developments
13.4 Serum Institute
13.4.1 Serum Institute Company Information
13.4.2 Serum Institute Oral Polio Vaccines (OPV) Product Offered
13.4.3 Serum Institute Oral Polio Vaccines (OPV) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Serum Institute Main Business Overview
13.4.5 Serum Institute Latest Developments
13.5 Tiantan Biological
13.5.1 Tiantan Biological Company Information
13.5.2 Tiantan Biological Oral Polio Vaccines (OPV) Product Offered
13.5.3 Tiantan Biological Oral Polio Vaccines (OPV) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Tiantan Biological Main Business Overview
13.5.5 Tiantan Biological Latest Developments
13.6 Panacea Biotec Ltd
13.6.1 Panacea Biotec Ltd Company Information
13.6.2 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product Offered
13.6.3 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Panacea Biotec Ltd Main Business Overview
13.6.5 Panacea Biotec Ltd Latest Developments
13.7 Bio-Med
13.7.1 Bio-Med Company Information
13.7.2 Bio-Med Oral Polio Vaccines (OPV) Product Offered
13.7.3 Bio-Med Oral Polio Vaccines (OPV) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Bio-Med Main Business Overview
13.7.5 Bio-Med Latest Developments
13.8 Halfkin Bio-Pharmaceuticals
13.8.1 Halfkin Bio-Pharmaceuticals Company Information
13.8.2 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product Offered
13.8.3 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.8.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Oral Polio Vaccines (OPV) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oral Polio Vaccines (OPV) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Trivalent OPV
Table 4. Major Players of Bivalent OPV
Table 5. Global Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 6. Global Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2022)
Table 7. Global Oral Polio Vaccines (OPV) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Oral Polio Vaccines (OPV) Revenue Market Share by Type (2017-2022)
Table 9. Global Oral Polio Vaccines (OPV) Sale Price by Type (2017-2022) & (USD/Doses)
Table 10. Global Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 11. Global Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2022)
Table 12. Global Oral Polio Vaccines (OPV) Revenue by Application (2017-2022)
Table 13. Global Oral Polio Vaccines (OPV) Revenue Market Share by Application (2017-2022)
Table 14. Global Oral Polio Vaccines (OPV) Sale Price by Application (2017-2022) & (USD/Doses)
Table 15. Global Oral Polio Vaccines (OPV) Sales by Company (2020-2022) & (M Doses)
Table 16. Global Oral Polio Vaccines (OPV) Sales Market Share by Company (2020-2022)
Table 17. Global Oral Polio Vaccines (OPV) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Oral Polio Vaccines (OPV) Revenue Market Share by Company (2020-2022)
Table 19. Global Oral Polio Vaccines (OPV) Sale Price by Company (2020-2022) & (USD/Doses)
Table 20. Key Manufacturers Oral Polio Vaccines (OPV) Producing Area Distribution and Sales Area
Table 21. Players Oral Polio Vaccines (OPV) Products Offered
Table 22. Oral Polio Vaccines (OPV) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Oral Polio Vaccines (OPV) Sales by Geographic Region (2017-2022) & (M Doses)
Table 26. Global Oral Polio Vaccines (OPV) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Oral Polio Vaccines (OPV) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Oral Polio Vaccines (OPV) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Oral Polio Vaccines (OPV) Sales by Country/Region (2017-2022) & (M Doses)
Table 30. Global Oral Polio Vaccines (OPV) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Oral Polio Vaccines (OPV) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Oral Polio Vaccines (OPV) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Oral Polio Vaccines (OPV) Sales by Country (2017-2022) & (M Doses)
Table 34. Americas Oral Polio Vaccines (OPV) Sales Market Share by Country (2017-2022)
Table 35. Americas Oral Polio Vaccines (OPV) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Oral Polio Vaccines (OPV) Revenue Market Share by Country (2017-2022)
Table 37. Americas Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 38. Americas Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2022)
Table 39. Americas Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 40. Americas Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2022)
Table 41. APAC Oral Polio Vaccines (OPV) Sales by Region (2017-2022) & (M Doses)
Table 42. APAC Oral Polio Vaccines (OPV) Sales Market Share by Region (2017-2022)
Table 43. APAC Oral Polio Vaccines (OPV) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Oral Polio Vaccines (OPV) Revenue Market Share by Region (2017-2022)
Table 45. APAC Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 46. APAC Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2022)
Table 47. APAC Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 48. APAC Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2022)
Table 49. Europe Oral Polio Vaccines (OPV) Sales by Country (2017-2022) & (M Doses)
Table 50. Europe Oral Polio Vaccines (OPV) Sales Market Share by Country (2017-2022)
Table 51. Europe Oral Polio Vaccines (OPV) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Oral Polio Vaccines (OPV) Revenue Market Share by Country (2017-2022)
Table 53. Europe Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 54. Europe Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2022)
Table 55. Europe Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 56. Europe Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Oral Polio Vaccines (OPV) Sales by Country (2017-2022) & (M Doses)
Table 58. Middle East & Africa Oral Polio Vaccines (OPV) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Oral Polio Vaccines (OPV) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Oral Polio Vaccines (OPV) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 62. Middle East & Africa Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 64. Middle East & Africa Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Oral Polio Vaccines (OPV)
Table 66. Key Market Challenges & Risks of Oral Polio Vaccines (OPV)
Table 67. Key Industry Trends of Oral Polio Vaccines (OPV)
Table 68. Oral Polio Vaccines (OPV) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Oral Polio Vaccines (OPV) Distributors List
Table 71. Oral Polio Vaccines (OPV) Customer List
Table 72. Global Oral Polio Vaccines (OPV) Sales Forecast by Region (2023-2028) & (M Doses)
Table 73. Global Oral Polio Vaccines (OPV) Sales Market Forecast by Region
Table 74. Global Oral Polio Vaccines (OPV) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Oral Polio Vaccines (OPV) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Oral Polio Vaccines (OPV) Sales Forecast by Country (2023-2028) & (M Doses)
Table 77. Americas Oral Polio Vaccines (OPV) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Oral Polio Vaccines (OPV) Sales Forecast by Region (2023-2028) & (M Doses)
Table 79. APAC Oral Polio Vaccines (OPV) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Oral Polio Vaccines (OPV) Sales Forecast by Country (2023-2028) & (M Doses)
Table 81. Europe Oral Polio Vaccines (OPV) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Oral Polio Vaccines (OPV) Sales Forecast by Country (2023-2028) & (M Doses)
Table 83. Middle East & Africa Oral Polio Vaccines (OPV) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Oral Polio Vaccines (OPV) Sales Forecast by Type (2023-2028) & (M Doses)
Table 85. Global Oral Polio Vaccines (OPV) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Oral Polio Vaccines (OPV) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Oral Polio Vaccines (OPV) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Oral Polio Vaccines (OPV) Sales Forecast by Application (2023-2028) & (M Doses)
Table 89. Global Oral Polio Vaccines (OPV) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Oral Polio Vaccines (OPV) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Oral Polio Vaccines (OPV) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sanofi Basic Information, Oral Polio Vaccines (OPV) Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Oral Polio Vaccines (OPV) Product Offered
Table 94. Sanofi Oral Polio Vaccines (OPV) Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. GSK Basic Information, Oral Polio Vaccines (OPV) Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK Oral Polio Vaccines (OPV) Product Offered
Table 99. GSK Oral Polio Vaccines (OPV) Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 100. GSK Main Business
Table 101. GSK Latest Developments
Table 102. Bibcol Basic Information, Oral Polio Vaccines (OPV) Manufacturing Base, Sales Area and Its Competitors
Table 103. Bibcol Oral Polio Vaccines (OPV) Product Offered
Table 104. Bibcol Oral Polio Vaccines (OPV) Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 105. Bibcol Main Business
Table 106. Bibcol Latest Developments
Table 107. Serum Institute Basic Information, Oral Polio Vaccines (OPV) Manufacturing Base, Sales Area and Its Competitors
Table 108. Serum Institute Oral Polio Vaccines (OPV) Product Offered
Table 109. Serum Institute Oral Polio Vaccines (OPV) Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 110. Serum Institute Main Business
Table 111. Serum Institute Latest Developments
Table 112. Tiantan Biological Basic Information, Oral Polio Vaccines (OPV) Manufacturing Base, Sales Area and Its Competitors
Table 113. Tiantan Biological Oral Polio Vaccines (OPV) Product Offered
Table 114. Tiantan Biological Oral Polio Vaccines (OPV) Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 115. Tiantan Biological Main Business
Table 116. Tiantan Biological Latest Developments
Table 117. Panacea Biotec Ltd Basic Information, Oral Polio Vaccines (OPV) Manufacturing Base, Sales Area and Its Competitors
Table 118. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product Offered
Table 119. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 120. Panacea Biotec Ltd Main Business
Table 121. Panacea Biotec Ltd Latest Developments
Table 122. Bio-Med Basic Information, Oral Polio Vaccines (OPV) Manufacturing Base, Sales Area and Its Competitors
Table 123. Bio-Med Oral Polio Vaccines (OPV) Product Offered
Table 124. Bio-Med Oral Polio Vaccines (OPV) Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 125. Bio-Med Main Business
Table 126. Bio-Med Latest Developments
Table 127. Halfkin Bio-Pharmaceuticals Basic Information, Oral Polio Vaccines (OPV) Manufacturing Base, Sales Area and Its Competitors
Table 128. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product Offered
Table 129. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
Table 130. Halfkin Bio-Pharmaceuticals Main Business
Table 131. Halfkin Bio-Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Oral Polio Vaccines (OPV)
Figure 2. Oral Polio Vaccines (OPV) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Polio Vaccines (OPV) Sales Growth Rate 2017-2028 (M Doses)
Figure 7. Global Oral Polio Vaccines (OPV) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oral Polio Vaccines (OPV) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Trivalent OPV
Figure 10. Product Picture of Bivalent OPV
Figure 11. Global Oral Polio Vaccines (OPV) Sales Market Share by Type in 2021
Figure 12. Global Oral Polio Vaccines (OPV) Revenue Market Share by Type (2017-2022)
Figure 13. Oral Polio Vaccines (OPV) Consumed in Public
Figure 14. Global Oral Polio Vaccines (OPV) Market: Public (2017-2022) & (M Doses)
Figure 15. Oral Polio Vaccines (OPV) Consumed in Private
Figure 16. Global Oral Polio Vaccines (OPV) Market: Private (2017-2022) & (M Doses)
Figure 17. Global Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2022)
Figure 18. Global Oral Polio Vaccines (OPV) Revenue Market Share by Application in 2021
Figure 19. Oral Polio Vaccines (OPV) Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Oral Polio Vaccines (OPV) Revenue Market Share by Company in 2021
Figure 21. Global Oral Polio Vaccines (OPV) Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Oral Polio Vaccines (OPV) Revenue Market Share by Geographic Region in 2021
Figure 23. Global Oral Polio Vaccines (OPV) Sales Market Share by Region (2017-2022)
Figure 24. Global Oral Polio Vaccines (OPV) Revenue Market Share by Country/Region in 2021
Figure 25. Americas Oral Polio Vaccines (OPV) Sales 2017-2022 (M Doses)
Figure 26. Americas Oral Polio Vaccines (OPV) Revenue 2017-2022 ($ Millions)
Figure 27. APAC Oral Polio Vaccines (OPV) Sales 2017-2022 (M Doses)
Figure 28. APAC Oral Polio Vaccines (OPV) Revenue 2017-2022 ($ Millions)
Figure 29. Europe Oral Polio Vaccines (OPV) Sales 2017-2022 (M Doses)
Figure 30. Europe Oral Polio Vaccines (OPV) Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Oral Polio Vaccines (OPV) Sales 2017-2022 (M Doses)
Figure 32. Middle East & Africa Oral Polio Vaccines (OPV) Revenue 2017-2022 ($ Millions)
Figure 33. Americas Oral Polio Vaccines (OPV) Sales Market Share by Country in 2021
Figure 34. Americas Oral Polio Vaccines (OPV) Revenue Market Share by Country in 2021
Figure 35. United States Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Oral Polio Vaccines (OPV) Sales Market Share by Region in 2021
Figure 40. APAC Oral Polio Vaccines (OPV) Revenue Market Share by Regions in 2021
Figure 41. China Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Oral Polio Vaccines (OPV) Sales Market Share by Country in 2021
Figure 48. Europe Oral Polio Vaccines (OPV) Revenue Market Share by Country in 2021
Figure 49. Germany Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Oral Polio Vaccines (OPV) Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Oral Polio Vaccines (OPV) Revenue Market Share by Country in 2021
Figure 56. Egypt Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Oral Polio Vaccines (OPV) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Oral Polio Vaccines (OPV) in 2021
Figure 62. Manufacturing Process Analysis of Oral Polio Vaccines (OPV)
Figure 63. Industry Chain Structure of Oral Polio Vaccines (OPV)
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
